The results of laboratory tests are affected by the collection and handling of the specimen, the particular laboratory and the method of analysis. They are also affected by variability within the individual and within the laboratory. Interpretation at one point in time should consider the position of the measurement within the laboratory reference range appropriate for the sample and the person being tested. Interpreting results over time should consider the likely variability of the measurement and the level of certainty required to identify a true change or absence of change. The more variable the measurement and the higher the required level of certainty, the larger the change between measurements needs to be before it can be considered clinically significant.
Introduction

Reference ranges
Quoted reference ranges depend on the method used in the laboratory, and the population from which the reference range was derived. The results from one method may be systematically different from those of another and therefore the reference ranges will be different. w w w. a u s t ra l i a n p re s c riber.com
Specimen collection and handling
Laboratory results can be affected by the procedures for specimen collection and handling ( 
Why normal people often have abnormal results
A multiple biochemical analysis can be performed by one machine and produce 20 results. Assuming these results were all independent of each other (which they are not) and that results from the reference population are normally distributed (which they may not be), only 36% of normal people will have all 20 results in the reference range. There will be 64% with at least one abnormal result (Box 1). However, the more abnormal the result and the more related tests are abnormal, the more likely the abnormality is clinically significant.
If you consider the 99% reference range (approx. ± 2.6 standard deviations) and the 99.9% reference range (approx. 
laboratory accuracy
We often know the within-laboratory, within-method variability as this is usually quoted by the laboratory. Modern laboratories provide remarkably consistent results for many analytestypical coefficients of variation (see Box 2) are 1-6% for the components of multiple biochemical analysis, electrolytes, calcium and phosphorus, and renal and liver function tests.
Box 1
Normal results in normal people
If the reference range covers 95% of results for a normal population, the chance of a healthy individual having a certain number of normal tests is: One result has been that the differences between laboratories for individual methods are now usually a small component of the overall variability of measurements.
Why values vary within one individual
In addition to the variations caused by specimen collection and It is much more difficult for laboratories to provide information on the total intra-individual variability than for the withinlaboratory, within-method variability which is automatically generated by their quality control programs. However, it is the total variability within an individual which is important when interpreting results.
Are changes in results caused by intra-individual variability or the effects of treatment?
One trap is the phenomenon of 'regression to the mean'. 4 Results within an apparently homogeneous group of patients are likely to lie within the 95% reference range for that A large difference between two measurements is more likely to be a signal of a true change than the result of the background noise of measurement variability. Similarly, the smaller the total intra-individual variability, the more likely a specific absolute change is a signal. The less likely the observed change is caused by variability, the surer one can be that the change is real.
These three elements are brought together in the concept of the least significant change. To be 80% confident the observed change is real, the change should exceed approximately twice the intra-
individual coefficient of variation (CV i ) (Box 3). For example:
n A total cholesterol which decreases from 7.0 to 5.6 mmol/L, after starting a statin, is a 20% fall from the initial value. The CV i for total cholesterol is 8% so the least significant change
Box 2
Coefficient of variation
The coefficient of variation (CV) is calculated as: CV = standard deviation of the measured value x 100 mean value
Variability is different at different absolute values of the measurement and is usually quoted at a specific clinically relevant value. For example:
CV for plasma sodium 0.8% at 139 mmol/L CV for plasma bilirubin 6.1% at 10 micromol/L
The coefficient of variation is one way of expressing the variability of biological measurements. Laboratories sometimes also refer to the imprecision of a measurement.
Box 3
least significant change 1 . The overall variability of the difference between two measurements is greater than the variability of the individual measurements: √ 2 CV i * 2. The more confident one wishes to be that the change in a measurement is a signal rather than noise, the greater the change needs to be relative to this: √ 2 CV i x z
The z value is used to refer to normally distributed values and describes the distance of a particular value from the mean in numbers of standard deviations (SD). The greater the distance from the mean (the z value) the less likely a result has occurred by chance.
z varies from 1.28 for 80% confidence to 2.6 for 99% confidence.
3. Generally 80% confidence is used (z = 1.28): Remember, the more tests you do the more likely you are to get at least one 'false positive' outside the laboratory reference range.
Aim to limit the number of tests to those that are relevant to the clinical situation rather than requesting a screening battery.
When assessing the effects of treatment, consider how long the treatment will take before the therapeutic effect reaches a steady state (e.g. 4-6 half-lives of a drug) and how long the biological response will take before the measurement you make reaches a steady state. Trying to assess therapeutic effects before treatment and response have reached a steady state can seriously underestimate the therapeutic effect. When starting a thiazolidinedione (glitazone) the full effect on blood glucose requires a steady state of the glitazone (pharmacokinetic) but also requires the shift in fat metabolism which in turn causes the reduction in glucose (biologic). Finally, the glycated haemoglobin (HbA1c) reflects the average blood glucose over the preceding 4-6 weeks because of the slow turnover of the red cells (biologic and pharmacokinetic). 5 The combination of these factors means that testing after one week of treatment may show little change in the HbA1c which may take 2-3 months to show the full effect of treatment.
Self-test questions
Another glycated protein (albumin, which becomes fructosamine) has a much faster turnover. It therefore reflects the average glucose over a shorter period (2-3 weeks).
One can reduce the variability of the measurement change by reducing the variability of the baseline and final measurements (for example, the mean of two measurements for each). If both initial and final measurements were repeated the variability of the change would be reduced to CV i (not √ 2 CV i ).
Using the microalbuminuria example, with two measurements before and after the intervention, the least significant change would be 51% (1.28 x 40%). You could then be 80% sure that the 60% observed change was real and not apparent.
Recommendations
When interpreting laboratory results it is important to know that the sample was collected and handled correctly. The appropriate reference range for the test should be used. Different laboratories may report different results on the same specimen.
When comparing results over time, use the same laboratory and method for testing. Consider the variability of results within the individual and the least significant change. This is the amount of difference between measurements that is likely to be a real biological 'signal' instead of resulting from the noise
